XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Restatement of Previously Issued Consolidated Financial Statements (Details 2) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Depreciation and amortization, deferred contract revenue, deferred contract cost, amortization of lease in excess of cash paid, deferred income taxes, accounts receivable, inventories, prepaid expenses and other assets $ 379,516 $ 450,550
Accounts payable and accrued expenses (522,825) 334,595
Cash provided by operating activity 1,568,551 29,584
Cash used in investing activities 13,825 (507,575)
Cash used in financing activities (1,495,563) 0
(Decrease) in cash 86,813 (477,991)
Cash at beginning of year 785,522 1,263,513
Cash at end of year 872,335 785,522
As Restated [Member]    
Net income (loss)   (1,313,996)
Depreciation and amortization, deferred contract revenue, deferred contract cost, amortization of lease in excess of cash paid, deferred income taxes, accounts receivable, inventories, prepaid expenses and other assets   1,008,985
Accounts payable and accrued expenses   334,595
Cash provided by operating activity   29,584
Cash used in investing activities   (507,575)
Cash used in financing activities   0
(Decrease) in cash   (477,991)
Cash at beginning of year 785,522 1,263,513
Cash at end of year   785,522
Previously Reported [Member]    
Net income (loss)   (1,056,070)
Depreciation and amortization, deferred contract revenue, deferred contract cost, amortization of lease in excess of cash paid, deferred income taxes, accounts receivable, inventories, prepaid expenses and other assets   1,008,985
Accounts payable and accrued expenses   76,669
Cash provided by operating activity   29,584
Cash used in investing activities   (507,575)
Cash used in financing activities   0
(Decrease) in cash   (477,991)
Cash at beginning of year $ 785,522 1,263,513
Cash at end of year   $ 785,522